Prolactinomas, dopamine agonists and headache: Two case reports

European Journal of Neurology

Volumn 10, Issue 2, 2003, Pages 169-173

  Levy, M J ^a   Matharu, M S ^a   Goadsby, Peter J ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Continua; Hemicrania; Indomethacin; Pituitary; SUNCT

Indexed keywords

ATENOLOL; BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; DOSULEPIN; FLUNARIZINE; GABAPENTIN; INDOMETACIN; PARACETAMOL; PIZOTIFEN; QUINAGOLIDE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HEADACHE; HUMAN; LABORATORY TEST; MIGRAINE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROLACTINOMA; RECURRENT DISEASE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AMENORRHEA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BROMOCRIPTINE; DOPAMINE AGONISTS; ERGOLINES; FEMALE; HEADACHE; HUMANS; INDOMETHACIN; MAGNETIC RESONANCE IMAGING; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA;

EID: 0037335139     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2003.00549.x     Document Type: Article

References (30)

1. Del Zompo M, Cherchi A, Palmas MA et al. (1998). Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 51:781-786.
2. Drummond PD, Lance JW (1984). Neurovascular disturbances in headache patients. Clin Exp Neurol 20:93-99.
3. Ferrari MD, Haan J, van Seters AP (1988). Bromocriptine-induced trigeminal neuralgia attacks in a patient with pituitary tumor. Neurology 38:1482-1484.
4. Forsyth PA, Posner JB (1993). Headaches in patients with brain tumors - a Study of 111 patients. Neurology 43:1678-1683.
5. Goadsby PJ, Lipton RB (1997). A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic features, including new cases. Brain 120:193-209.
6. Goadsby PJ, Matharu MS, Boes CJ (2001). SUNCT syndrome or trigeminal neuralgia with lacrimation. Cephalalgia 21:82-83.
7. Kapicioglu S, Gokce E, Kapicioglu Z, Ovali E (1997). Treatment of migraine attacks with a long-acting somatostatin analogue (octreotide, SMS 201-995). Cephalalgia 17:27-30.
8. Levy MJ, Jager HR, Matharu MS, Goadsby PJ (2002). Pituitary tumours and headache: does size matter? Cephalalgia 22:592.
9. Mascia A, Afra J, Schoenen J (1998). Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data. Cephalalgia 18:174-182.
10. Massiou H, Launay JM, Levy C, El Amran M, Emperauger B, Bousser M-G (2002). SUNCT syndrome in two patients with prolactinomas and bromocriptine-induced attacks. Neurology 58:1698-1699.
11. May A, Bahra A, Buchel C, Frackowiak RSJ, Goadsby PJ (1998). Hypothalamic activation in cluster headache attacks. The Lancet 351:275-278.
12. May A, Bahra A, Buchel C, Frackowiak RSJ, Goadsby PJ (2000). PET and MRA findings in cluster headache and MRA in experimental pain. Neurology 55:1328-1335.
13. May A, Lederbogen S, Diener H-C (1994). Octreotide dependency and headache: a case report. Cephalalgia 14:303-304.
14. Milos P, Havelius U, Hindfelt B (1996). Clusterlike headache in a patient with a pituitary adenoma. With a review of the literature. Headache 36:184-188.
15. Nagel-Leiby S, Welch KMA, D'Andrea G, Grunfeld S, Brown E (1990). Event-related slow potentials and associated catecholamine function in migraine. Cephalalgia 10:317-329.
16. Otsuka F, Kageyama J, Ogura T, Makino H (1998). Cluster headache dependent upon octreotide injection. Headache 38:629.
17. Pareja JA, Antonaci F, Vincent M (2001). The hemicrania continua diagnosis. Cephalalgia 21:940-946.
18. Pascual J, Freijares J, Berciano J, Pesquera C (1991). Analgesic effect of octreotide in headache associated with acromegaly is not mediated by opioid mechanisms. Pain 47:341-344.
19. Peres MFP, Silberstein SD, Nahmias S et al. (2001). Hemicrania continua is not that rare. Neurology 57:948-951.
20. Peres MFP, Siow HC, Rozen TD (2002). Hemicrania continua with aura. Cephalalgia 22:246-248.
21. Peroutka SJ, Wilhoit T, Jones K (1997). Clinical susceptibility to migraine aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 49:201-206.
22. Popovic V, Pannovic VR, Micic D et al. (1988). The analgesic effect and development of dependency to somatostatin analogue (octreotide) in headache associated with acromegaly. Hormones Metabolic Res 20:250-251.
23. Porta-Etessam J, Ramos-Carrasco A, Berbel-Garcia A, Martinez-Salio A, Benito-Leon J (2001). Clusterlike headache as first manifestation of a prolactinoma. Headache 41:723-725.
24. Rasmussen BK, Olesen J (1992). Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 12:221-228.
25. Richman PB, Allegra J, Eskin B et al. (2002). A randomized clinical trial to assess the efficacy of intramuscular droperidol for the treatment of acute migraine headache. Am J Emergency Med 20:39-42.
26. Schmidt K, Althoff PH, Harris AG, Prestele H, Schumm-Draeger PM, Usadel KH. (1993). Analgesic effect of the somatostatin analogue octreotide in two acromegalic patients: a double-blind Study with long-term follow-up. Pain 52:223-227.
27. Sicuteri F, Geppetti P, Marabini S, Lembeck F (1984). Pain relief by somatostatin in attacks of cluster headache. Pain 18:359-365.
28. Sjaastad O, Spierings EL (1984). Hemicrania continua: another headache absolutely responsive to indomethacin. Cephalalgia 4:65-70.
29. Suwanwela N, Phanthumchinda K, Kaoropthum S (1994). Headache in brain tumor: a cross-sectional Study. Headache 34:435-438.
30. Tfelt-Hansen P, Paulson OB, Krabbe AE (1982). Invasive adenoma of the pituitary gland and chronic migrainous neuralgia. A rare coincidence or a causal relationship? Cephalalgia 2:25-28.